Unknown

Dataset Information

The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies.


ABSTRACT: Uses of real-world data in drug safety and effectiveness studies are often challenged by various sources of bias. We undertook a systematic search of the published literature through September 2020 to evaluate the state of use and utility of negative controls to address bias in pharmacoepidemiologic studies. Two reviewers independently evaluated study eligibility and abstracted data. Our search identified 184 eligible studies for inclusion. Cohort studies (115, 63%) and administrative data (114, 62%) were, respectively, the most common study design and data type used. Most studies used negative control outcomes (91, 50%), and for most studies the target source of bias was unmeasured confounding (93, 51%). We identified 4 utility domains of negative controls: 1) bias detection (149, 81%), 2

SUBMITTER: Zafari Z 

PROVIDER: S-EPMC11484649 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature